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OVER THE past ten years, non-invasivepositive pressure ventilation (NIPPV) tech-niques have increasingly been used in the
treatment of patients with chronic respiratory
insufficiency to manage acute or chronic respira-
tory failure without intubation and conventional
mechanical ventilation. In selected patient groups,
this treatment option is rapidly becoming an
accepted method of supporting ventilation with-
out the hazards associated with endotracheal
intubation (Juniper and Hardinge 1998). Bi-level
positive airway pressure (BiPAP) ventilation was
introduced to clinical practice on the respiratory
medical ward at the Ayr Hospital three years
ago. BiPAP non-invasive ventilation increases the
treatment options for patients with type 2 respi-
ratory failure, who were traditionally managed
with drug therapy or referred to intensive care
for conventional ventilation.  
Mechanical ventilation was being used in the
treatment of respiratory failure as early as the
1840s (Marcet 1854), although it was not until
the 1950s that non-invasive negative pressure
techniques, such as the ‘iron lung’, were more
extensively used. Further advancements in tech-
nology and the development of endotracheal
tubes preceded invasive ventilation techniques,
which became the standard method of supporting
or assisting ventilation. There are, however, a
number of complications associated with invasive
ventilation techniques: decreased cardiac output,
aspiration, tension pnuemothorax, bronchospasm,
laryngeal trauma, sinusitis and pneumonia (Juniper
and Hardinge 1998, Stauffer et al 1981). Factors
such as the patient’s age, quality of life and pre-
dicted ventilatory dependence should be taken
into account before invasive ventilatory manage-
ment is initiated. This type of therapy might be
considered inappropriate for some patients, such
as those suffering from end-stage respiratory
failure who are oxygen dependent, even in the
home setting. Until about six years ago this was
the only option available to support patients
with a life-threatening reversible deterioration in
respiratory function. Nasal and full-face mask
positive pressure ventilation (NPPV) techniques
are rapidly becoming an accepted method of
non-invasive ventilation and can reduce hazards
associated with endotracheal intubation, as well
as decreasing hospital costs by preventing patient
admission to intensive care units (Kannan 1999).
Juniper and Hardinge (1998) acknowledge that
NPPV is being used increasingly in high depend-
ency areas and on general wards. At Ayr Hospital,
full-face or nasal mask BiPAP ventilation, via the
ventilator (Fig. 1), is used on the respiratory ward
to treat acute respiratory failure due to exacer-
bation of chronic obstructive pulmonary disease
(COPD). Over the past two years, the uses of this
non-invasive ventilator have increased. It is now
being successfully used in the intensive care and
high dependency units to treat patients suffering
from cardiogenic pulmonary oedema and pneu-
monia, and also for patients who are difficult to
wean or who fail to wean from invasive mechan-
ical ventilation. 
Non-invasive ventilation refers to techniques that
provide and enhance alveolar ventilation without
the use of an endotracheal airway and can be
accomplished using positive or negative pressure
techniques (Jasmer et al 1997, Kannan 1999,
Shudham 1998). NPPV gives the patient breath-
ing assistance by delivering a pressurised gas
flow through a tight-fitting mask. NPPV aids
breathing by:
 Decreasing the work of breathing.
 Increasing the volume of inhaled air in each
breath (tidal volume).
 Increasing blood oxygen levels.
NIPPV and BiPAP
History of ventilation
Non-invasive ventilation techniques provide
and enhance alveolar ventilation without
the need for an endotracheal airway. These
techniques are increasingly being used by
nurses to manage patients with type 2
respiratory failure. The author outlines the
advantages of, and criteria and
contraindications for, using bi-level positive
airway pressure (BiPAP).
Summary
BiPAP This is the newest form of non-invasive
ventilation. In normal respiration, each breath
consists of two phases: an inspiratory and an
expiratory phase. BiPAP works by providing
assistance during the inspiratory phase of
respiration and preventing airway closure during
the expiratory phase. Assistance during the
inspiratory phase is in the form of pressure
support. As the patient breathes in, the
equipment generates a positive pressure
(pressure higher than the atmospheric pressure)
at a level pre-set by the clinician. This positive
pressure support is termed ‘inspiratory positive
airway pressure’ (IPAP). IPAP increases the
patient’s tidal volume, thus increasing minute
ventilation (tidal volume x respiratory rate per
minute) and ultimately alveolar ventilation. An
increase in minute and alveolar ventilation
decreases carbon dioxide levels in the arterial
blood (PaCO2) and alleviating dyspnoea, thus
reducing the use of accessory muscles.
Pressure support ends at the start of the expi-
ratory phase of respiration, but a continuous
positive pressure, known as positive end expiratory
pressure (PEEP) or continuous positive airway
pressure (CPAP), is maintained within the airways.
PEEP and CPAP apply positive pressure at the end
of each expiration, which helps to inflate the
alveoli and keep them open. This increases the
surface area for gaseous exchange. On the BiPAP
machine, PEEP/CPAP is termed ‘expiratory positive
airway pressure’ (EPAP). EPAP increases the func-
tional residual capacity of the lungs (the volume
of air that remains in the lungs at the end of nor-
mal expiration) and decreases or prevents airway
closure. Areas of collapsed lung tissue resulting
from atelectasis can be re-expanded and fluid
accumulation due to pulmonary oedema can be
prevented or reduced. Increasing the functional
residual capacity of the lung can result in an
increase in arterial oxygen (PaO2) levels, however,
supplemental oxygen can be administered if
required.
The BiPAP ventilator alternates between IPAP and
EPAP levels at respiratory frequencies that synchro-
nise with the patient’s breathing pattern. As the
patient inspires, the ventilator delivers IPAP, which
stops as the patient expires, but pressure within
the airways remains positive because of the EPAP. 
Different modes of non-invasive ventilation
Three different modes of non-invasive ventilation
are available on the BiPAP ventilator: spontaneous,
spontaneous/timed and timed. In spontaneous
mode, the patient triggers all inspirations; in
spontaneous/timed mode the number of breaths
per minute (BPM) is pre-set and these are
synchronised with the patient’s breathing
activity. If the patient does not initiate a breath,
the ventilator will trigger the inspiratory phase,
giving the patient a ventilator-assisted breath.
Spontaneous mode is used in patients who have
an adequate respiratory rate, while spontaneous/
timed mode is used when the patient is not
maintaining an adequate respiratory rate and a
back-up rate is desirable. Timed mode can be
useful in patients who have problems
synchronising their breathing with BiPAP, such as
patients with tachypnoea. In timed mode, the
percentage of the respiratory cycle for
inspiration can be manipulated, thus allowing
variable times for inspiration depending on the
patient’s condition. Figure 2 shows the control
settings on a BiPAP ventilator.
Criteria for commencing BiPAP In an acute
exacerbation of COPD, the work of breathing is
increased, which results in reduced alveolar
ventilation, causing carbon dioxide (CO2)
retention, a reduction in oxygen (O2) levels and
respiratory acidosis (Stauffer et al 1981). BiPAP
ventilation results in:
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Fig. 1. BiPAP non-invasive ventilator
Fig. 2. Control settings on BiPAP ventilator
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 A decrease in respiratory muscle effort due to
assisted inspiration.
 Increased tidal volumes as a result of a 
reduction in inspiratory effort.
 Reduced respiratory rate as the efficiency of
breathing is increased.
 Reduced CO2 levels as alveolar ventilation is
improved.
 Increased O2 levels due to increased functional
residual capacity.
It is important that the following criteria are met
before starting patients on BiPAP:
 The patient must be conscious and breathing
spontaneously.
 He or she must have an adequate gag and
cough reflex.
 The patient must be cognitively aware so that
he or she knows if and when the mask needs to
be removed, for example, if the patient vomits.
Correct placement, position and size of the full-
face or nasal mask (Fig. 3) is a key factor in the
success of BiPAP ventilation. The full-face mask
is used in Ayr Hospital. From personal experience
these masks are better than nasal for patients
who are dyspnoeic or tachypnoeic as they tend
to mouthbreathe, thus reducing the effective-
ness of non-invasive ventilation. The mask is
held in position using restraining straps, ensuring a
tight seal to maintain expiratory positive airway
pressure (Fig. 4). If the mask is fitted too tightly,
pressure necrosis can develop, especially over the
bridge of the nose, and the patient might be
uncomfortable and might not tolerate the ther-
apy. Masks that are too loose cause air leaks,
which reduce the efficiency of the system and
EPAP. It is imperative that the mask has a quick
release system (Fig. 4) that can be operated by
the patient should he or she need to remove it.
Contra-indications for the use of BiPAP ventila-
tion are listed in Box 1.
Advantages of BiPAP As with other modes of
non-invasive ventilation, BiPAP has a number of
advantages:
 The ability to preserve normal swallowing,
speech, feeding and coughing mechanisms.
 Normal humidification of inspired gases is
maintained because the upper airway is not
bypassed.
 The absence of an endotracheal airway means
that the patient does not require sedation.
Patients at Ayr Hospital are assessed for BiPAP by
the nursing staff. They must meet the criteria
outlined in the protocol before BiPAP is initiated
(Box 2). Patients who are unable to protect the
airway or clear secretions, and those with a
pneumothorax, lobar pneumonia, acute severe
asthma or a systolic blood pressure below
85mmHg are excluded from BiPAP. 
Haemodynamic instability, such as uncontrolled
cardiac dysrhythmias or low systolic blood pres-
sure below 85mmHg and severe hypoxaemia
with a PaO2 below 60mmHg (8kPa) on 100 per
cent oxygen can contraindicate the use of BiPAP
(Kannan 1999). Arterial blood gases should
always be checked and the patient assessed to
ensure that he or she meets the entry criteria
before commencing BiPAP. If the patient is suit-
able for BiPAP, the procedure should be
explained fully and he or she measured for cor-
rect mask size. Familiarising the patient with the
equipment is an important aspect of initiating
therapy, as this information might help to relieve
patient anxiety about starting ventilation. The
patient should be shown the mask and instructed
in the use of the quick release strap. The impor-
tance of keeping the mask on should be
explained and the patient informed about the
noise the machine generates. The initial BiPAP
settings are:
 IPAP – set at 8cmH2O.
 EPAP – set at 4cmH2O.
 Oxygen can be connected directly to the face
mask using oxygen tubing and is delivered at
an initial flow rate of one litre per minute.
Adjusting BiPAP Arterial blood gases are
repeated one hour, four hours and eight hours
after commencing BiPAP, or more often if
clinically indicated. Monitoring pulse oximetry
Initiating BiPAP therapy
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 Lobar pneumonia
 Acute exacerbation of
asthma
 Patients unable to tolerate
mask
 Patients susceptible to
gastric distention requiring
nasogastric tube placement
 Patients with bullous disease




 Allergy to face mask
material
 Patients who need to
remove mask frequently for
expectoration
Box 1. Contraindications for
BiPAP
Fig. 3. Mask sizing chart








alone is insufficient in assessing the full effects of
BIPAP as it gives no indication of PaCO2 levels.
IPAP is gradually increased over 30-60 minutes to
the maximum level the patient will comfortably
tolerate: this is usually 12-20cmH2O. The
percentage of oxygen can be adjusted on
consultation with medical staff to maintain
oxygen saturation above 90 per cent.
Patients require a high level of psychological
preparation and support during the initial stages
of BiPAP ventilation. Breathless patients are often
anxious and agitated as a result of hypoxia, and
might require constant monitoring and assess-
ment until ventilation therapy has been estab-
lished. Once the patient is adequately ventilated,
agitation usually lessens. Psychological support
should include an explanation of the equipment
used, including the ventilator. The patient and
his or her family should be given reassurance
regarding safety aspects and the need for BiPAP.
Accurate mask fitting is vital to the success of
this therapy and time must be spent familiarising
the patient with the mask and how to remove it
using the quick release strap. Careful explanation
about the need for wearing the mask continu-
ously is also necessary. The most comfortable
mask interface should be used as this will help to
ensure patient compliance with therapy. The
ventilator compensates for small air leaks from
the masks and these are permissible provided
they are not near the patient’s eyes as this can
lead to drying and conjunctivitis (Kannan 1999).
Compensation for small air leaks means that
maintaining an airtight mask is unnecessary,
which can improve patient compliance. As a
tight-fitting mask can cause pressure necrosis at
the bridge of the nose, frequent inspection of
this site should be carried out. Various pressure-
relieving cushions for the mask are available to
reduce or eliminate this problem and promote
comfort.
Patients on BiPAP require close observation and
monitoring of vital signs until their condition
stabilises. Continuous monitoring of oxygen sat-
uration is vital. Continuous ECG monitoring and
recording of the patient’s blood pressure at 15-
minute intervals is advocated during the acute
period. Cardiac monitoring can be discontinued
and the frequency of blood pressure measurement
reduced once the patient’s condition has stabilised.
Observation of respiratory rate and use of acces-
sory muscles gives an indication of how the
patient is responding to ventilation therapy. A
reduction in respiratory rate and accessory muscle
use is expected as the patient’s condition improves.
Gastric distension is a possible complication of
BiPAP non-invasive ventilation and frequent
assessment of the abdomen should be carried out.
If gastric distension is present, a nasogastric tube
should be passed to release the air. 
As the patient’s condition stabilises, BiPAP can
be stopped intermittently for short periods of up
to 15 minutes to allow oral intake. The mask can
also be removed for expectoration. 
The introduction of BiPAP non-invasive ventila-
tion for patients on a general ward requires ward
nurses to learn about new equipment and develop
new skills in caring for this group of patients.
The lecturer practitioner and ward sister at Ayr
hospital developed a training programme in the
use of BiPAP equipment and mask fitting for all
ward, intensive care and high dependency unit
staff. Nursing staff also attended lectures on
blood gas analysis and interpretation, as well as
the mechanisms of BiPAP ventilation. Support for
ward nurses is provided by senior nurses, the
ward sister and lecturer-practitioner.
The introduction of BiPAP ventilation on the
respiratory ward has provided another treatment
option for those patients who meet the inclusion
criteria. This initiative appears to have resulted in
a reduction in the number of patients referred to
intensive care for conventional ventilation methods,
although these figures have not been audited.
BiPAP ventilation has also been used to success-
fully treat patients on the intensive care unit who
are not suitable for invasive ventilation. An
informal audit of intensive care patients has
demonstrated a success rate of over 75 per cent
and a more detailed long-term audit is planned
in the near future.
This method of respiratory support is a nurse-led
therapy. Increased knowledge has empowered
the nursing staff to be more proactive in the treat-
ment and management of respiratory patients. To
ensure that patients are cared for by suitably
qualified staff, BiPAP ventilation is only carried
out on the respiratory ward and high dependency
and intensive care units.
BiPAP is a safe and effective means of support-
ing ventilation in acute respiratory failure. The
main benefit for many patients is that it decreases
the need for endotracheal intubation and inva-
sive ventilation. Another advantage of using
BiPAP over other more invasive forms of ventila-
tion is that patients remain in control of their
treatment and can communicate, eat and drink
while experiencing improvement in respiratory
symptoms  
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Respiratory failure:




 Chest wall deformity, for
example kyphoscoliosis
Arterial blood gases:
 PaO2 (on air) < 50mmHg
(7kPa) or PaO2 (on oxygen)
< 70mmHg (10kPa)
 PaCO2 > 45mmHg (6.5kPa)
 pH < 7.35
Baseline measurements for the





 Use of accessory muscles
 Breath sounds
 Arterial blood gases
 Oxygen saturation (SpO2)
 Chest X-ray
Box 2. Entry criteria for
BiPAP ventilation
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